Mr. Noboru Shimizu Joined MicroPort<sup>®</sup> CRM as Vice-President, Country Manager Japan, and Head of Commercial Operations of MicroPort<sup>®</sup> CRM Japan Co. Ltd.

Clamart, France – November 26th, 2018 - MicroPort® CRM (a business unit of MicroPort Scientific Corporation), is pleased to announce that Mr. Noboru Shimizu has joined us to take on the role of Vice-President, Country Manager Japan, and head of commercial operations of MicroPort® CRM Japan Co. Ltd., a subsidiary created in August 2018, Tokyo, Japan.
 
Mr. Shimizu has an outstanding track record in working for large multi-national companies such as McKinsey, Guidant, Boston Scientific and most recently IQVIA (Quintiles). Mr. Shimizu brings a wealth of experience and expertise to MicroPort® CRM.
 
Mr. Shimizu graduated from the University of Tokyo with a Bachelor of Science, and the Wharton School at the University of Pennsylvania with an MBA.
 
"The Japanese market is of primary importance to our CRM business. Shimizu-San's long-term strategic vision is fully aligned with that of MicroPort® CRM and I believe that this vision, together with his deep knowledge of the Japanese healthcare market and strong business acumen, will ensure MicroPort® CRM Japan's development and success in the near future" said Benoît Clinchamps, President of MicroPort® CRM.
 
"I'm convinced that Shimizu-Sans's previous CRM experience along with his excellent managerial skills and sound knowledge of the local environment will help guide our organization as we work to widen our reach among Japanese physicians and patients providing greater access to the very best technologies that MicroPort® CRM has to offer," said Philippe Wanstok, Senior Vice President, Global Sales, MicroPort® CRM.

 

About MicroPort® CRM
 
Pioneering physiological therapies in cardiac rhythm management. Driven by our expert R&D teams and state-of-the-art manufacturing facilities across the globe, MicroPort® CRM conceives, designs and develops solutions for the management of cardiac rhythm disorders and heart failure. Headquartered in Paris, our precise technologies are manufactured in France, Italy, the Dominican Republic; and for the Chinese market, in China. MicroPort® CRM is part of MicroPort Scientific Corporation.
 
For more information visit www.crm.microport.com